Brett E Skolnick Selected Research

Factor VIIa (Activated Factor VII)

1/2010	Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
3/2009	Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?
5/2008	Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
3/2008	Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage.
3/2007	Determinants of intracerebral hemorrhage growth: an exploratory analysis.
1/2007	Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage.
10/2006	Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.
1/2006	Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial.
2/2005	Recombinant activated factor VII for acute intracerebral hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brett E Skolnick Research Topics

Disease

10	Cerebral Hemorrhage 01/2010 - 01/2005
8	Hemorrhage 10/2011 - 10/2006
6	Hematoma 05/2008 - 01/2005
2	Inflammation (Inflammations) 11/2017 - 06/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2015 - 12/2014
2	Hemorrhagic Stroke 01/2010 - 03/2009
2	Atherosclerosis 01/2010 - 03/2008
2	Ischemic Stroke 01/2010 - 03/2008
2	Body Weight (Weight, Body) 05/2008 - 02/2005
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2008 - 01/2006
2	Cerebral Infarction 01/2006 - 02/2005
1	Multiple Sclerosis 01/2019
1	Crohn Disease (Crohn's Disease) 11/2017
1	Sickle Cell Anemia (Hemoglobin S Disease) 06/2017
1	Hemoglobinopathies 06/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015
1	Hemophilia A (Haemophilia) 10/2011
1	Hypertension (High Blood Pressure) 01/2010
1	Brain Ischemia (Cerebral Ischemia) 01/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Stroke (Strokes) 05/2008
1	Traumatic Cerebral Hemorrhage 04/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2008
1	Coma (Comas) 10/2006
1	Pulmonary Embolism 01/2006
1	Edema (Dropsy) 01/2005
1	Vascular System Injuries 01/2005
1	Parkinson Disease (Parkinson's Disease) 04/2002

Drug/Important Bio-Agent (IBA)

13	recombinant FVIIa (rFVIIa)FDA Link 10/2011 - 01/2005
9	Factor VIIa (Activated Factor VII)IBA 01/2010 - 02/2005
5	Hemostatics (Antihemorrhagics)IBA 03/2009 - 01/2006
4	Factor VII (Proconvertin)IBA 01/2010 - 01/2005
2	Monoclonal AntibodiesIBA 11/2017 - 01/2015
2	Progesterone FDA LinkGeneric 01/2015 - 12/2014
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2010 - 03/2007
2	Pharmaceutical PreparationsIBA 01/2010 - 03/2008
2	TESIBA 01/2010 - 03/2008
1	ozanimodIBA 01/2019
1	C-Reactive ProteinIBA 11/2017
1	Immunoglobulins (Immunoglobulin)IBA 11/2017
1	beta-Globins (beta Globin)IBA 06/2017
1	Hemoglobins (Hemoglobin)IBA 06/2017
1	Immunologic Factors (Immunomodulators)IBA 06/2017
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 06/2017
1	Carbon MonoxideIBA 06/2017
1	FletikumabIBA 01/2015
1	Clopidogrel (Plavix)FDA Link 10/2011
1	IsoantibodiesIBA 10/2011
1	Warfarin (Coumadin)FDA LinkGeneric 08/2010
1	Biological ProductsIBA 04/2008
1	CholesterolIBA 03/2007
1	CreatinineIBA 03/2007
1	Glucose (Dextrose)FDA LinkGeneric 03/2007
1	EnzymesIBA 01/2006
1	Troponin IIBA 01/2005

Therapy/Procedure

6	Therapeutics 10/2011 - 04/2002